China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Nefertiti Brown, MDs life is on pause right now. The 39-year-old physician is quarantined in her home, awaiting results from a COVID-19 test she took nearly two weeks ago. Dr. Brown, a graduate of the University of Pittsburgh School of Medi

Abbotts new ID NOW COVID-19 test, which earned emergency use authorization (EUA) from FDA last week, was highlighted during President Donald Trumps COVID-19 taskforce press briefing on March 30. FDA Commissioner Stephen Hahn spoke about the

A smallSan Diego, CA-based company has joined the ongoing battle against the new coronavirus. Cue Medical secured a U.S. government contract to deliver itsportablepoint-of-care diagnostic test for the detection of SARS-Cov-2, the virus that

Grail has some solid results coming from its multi-cancer early detection blood test. The liquid biopsy specialist revealed data that shows its technology can detect more than 50 cancer types across all stages, with a very low false-positiv

Siemens Healthineers is adding more firepower in the fight to make more novel coronavirus (SARS-CoV-2) diagnostics available. The company said its Fast Track Diagnostics (FTD) SARS-COV-2 Assay is already being shipped in Europe for research

The Austin TX-based company was granted Emergency Use Authorization for the Aries SARS-CoV-2 Assay and the NxTAG CoV Extended Panel to help in the detection of the novel coronavirus.

NEW YORK Bio-Rad Laboratories has developed an assay to detect the SARS-CoV-2 virus, cause of the COVID-19 pandemic, using its droplet digital PCR systems, and similar ddPCR tests have been shown in recent preliminary studies to reduce fals

NEW YORK Myriad Genetics said Monday that it has submitted a supplementary application to the Japanese Ministry of Health Labor and Welfare for use of its BRACAnalysisDiagnostic System as a companion diagnostic to identify patients with met

NEW YORK Rendu Biotechnology said on Monday that it has received emergency approval from Chinas National Medical Products Administration for a SARS-Cov-2 nucleic acid detection kit. According to Shanghai-based Rendu, the kit uses RNA-specif

NEW YORK Thermo Fisher Scientific said on Monday that it has priced an offering of 1.2 billion ($1.33 billion) worth of euro-denominated senior notes. The Waltham, Massachusetts-based company is offering 6 billion worth of senior notes with